Short answer: Willow sells compounded semaglutide for $299 a month all-in, and Hims sells FDA-approved GLP-1s from $298 a month all-in. For…
September 22, 2026
Eden Health (NYC) employer care
Quick verdict
- Best for
- former members checking how employer access to Eden’s former virtual-first care now works through Centivo
- Key feature
- Former employer-focused primary care, telehealth, mental-health support and navigation acquired by Centivo in 2024.
Eden Health (NYC) was an employer-focused virtual-first medical provider combining primary care, mental-health support and care navigation. Centivo announced its acquisition in May 2024. Eden-related clinical entities remain referenced in current Centivo Care terms, while member access is now tied to Centivo or an employer health plan. This is not the separate consumer weight-management business currently using the Eden name at eden.health.
Our rating
Pros and cons
Pros
- Historical service model combined primary care, telehealth and navigation.
- Employer-based plans may make care affordable for eligible members.
- Centivo continues to describe an integrated virtual primary-care offering.
Cons
- The standalone Eden Health business was acquired; present access depends on Centivo and employer plans.
- No public individual signup price or universal member price is available.
- Similar Eden-branded consumer wellness services must not be confused with this former NYC employer provider.
How it compares
Short answer: both mainly sell compounded GLP-1s, which are not FDA-approved. Mochi Health is cheaper at low doses, from $139 a month…
September 22, 2026
Short answer: Hims and Noom are different kinds of programs. Hims sells FDA-approved brand-name GLP-1s with a $149 membership, from $298 a…
September 22, 2026
User reviews
No user reviews yet.